The Presidential Initiative for Unlocking the Healthcare Value Chain (PVAC) welcomes investments that strengthen Nigeria’s capacity to produce essential health products locally and improve long-term medicine security. In that context, Emzor’s Active Pharmaceutical Ingredients (API) project is relevant to the broader national effort to deepen domestic pharmaceutical manufacturing and reduce structural dependence on imported inputs. PVAC’s mandate is to help unlock the healthcare value chain through cross-sector coordination, policy enablement, investment facilitation, technical partnerships, and support for local manufacturing across priority value chains. This includes advancing the conditions required for Nigeria to increase local production, create quality jobs, attract capital, strengthen supply resilience, and position the country as a competitive health manufacturing hub in Africa.
- +PVAC statement on Emzor Pharmaceuticals API project
API production is one of PVAC’s priority areas because it sits at the foundation of pharmaceutical self-reliance.
API production is one of PVAC’s priority areas because it sits at the foundation of pharmaceutical self-reliance. The development of local API capacity supports national objectives on medicine availability, affordability, health security, and industrial growth, while also contributing to Nigeria’s ambition to serve regional markets under frameworks such as AfCFTA.
Within this broader vision, Emzor’s project reflects the kind of industrial capacity expansion that can support national healthcare goals if executed to high quality, regulatory, and market standards. Its focus on local API manufacturing aligns with ongoing efforts to stimulate domestic production, strengthen supply chains, and expand the range of health products and technologies that can be made in Nigeria.
PVAC therefore recognizes the strategic relevance of initiatives such as Emzor’s API project to the sector’s development and to the implementation of the Federal Government’s healthcare value chain agenda specifically, initiatives like the Affordable Diagnostics and Medicines for Malaria Funding model (ADMFm). By demonstrating long-term commitment to high-quality local API manufacturing, beginning with antimalarials, Emzor is contributing in a tangible way to national goals on medicine security, industrial growth and regional competitiveness, and exemplifying the kind of private-sector leadership PVAC seeks to enable across the pharmaceutical value chain.
